Cytek Biosciences, Inc. CTKB Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$66.54M— | —— | —— | $2.48M— | ||
| $7.58M+5.1% | $7.21M+19.2% | $6.05M+143% | $2.49M+101% | ||
| $24.59M-8.4% | $26.85M+21.8% | $22.05M+32.9% | $16.6M+152% | ||
| -$4.79M-119% | $25.38M— | —— | —— | ||
| $4.08M+15.9% | $3.53M-24.2% | $4.65M-52.3% | $9.75M+123% | ||
| —— | -$85M— | —— | -$55.91M-166% | ||
| —— | $21.62M— | —— | —— | ||
| $5.58M+33.4% | $4.18M— | $0-100% | $2.98M— | ||
| $4.75M+752% | $557K-1.4% | $565K+1,030% | $50K— | ||
| —— | -$15.82M+62.2% | -$41.81M-858% | $5.51M-97.4% | ||
| —— | -$68.89M— | —— | -$65.12M-133% | ||
| -$8.77M-140% | $21.85M+3,352% | $633K+103% | -$21.98M-8,363% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Cytek Biosciences, Inc. generate?
- Cytek Biosciences, Inc. (CTKB) generated -$7.4M in operating cash flow over the trailing twelve months.
- What is Cytek Biosciences, Inc.'s free cash flow?
- After $5.4M of capital expenditures, Cytek Biosciences, Inc.'s free cash flow was -$12.7M over the trailing twelve months, down 172.6% year over year.
- Where does Cytek Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Cytek Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
